Corteva, Inc. (NYSE: CTVA) is a Basic Materials company in the Agricultural Inputs industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | S&P 500 | P/E | 56.13 | EPS (ttm) | 1.51 | Insider Own | 0.39% | Shs Outstand | 668.82M | Perf Week | -3.40% |
| Market Cap | 56.68B | Forward P/E | 20.44 | EPS next Y | 4.15 | Insider Trans | 0.00% | Shs Float | 667.84M | Perf Month | 10.83% |
| Enterprise Value | 59.19B | PEG | 5.02 | EPS next Q | -0.42 | Inst Own | - | Short Float | 2.17% | Perf Quarter | 12.98% |
| Income | 1.01B | P/S | 3.18 | EPS this Y | 148.69% | Inst Trans | - | Short Ratio | 3.47 | Perf Half Y | 11.06% |
| Sales | 17.81B | P/B | 2.23 | EPS next Y | 10.44% | ROA | 2.42% | Short Interest | 14.48M | Perf YTD | 26.44% |
| Book/sh | 37.98 | P/C | 23.97 | EPS next 5Y | 11.18% | ROE | 4.08% | 52W High | 90.97 -6.84% | Perf Year | 16.18% |
| Cash/sh | 3.54 | P/FCF | 93.42 | EPS past 3/5Y | 0.42% 11.95% | ROIC | 6.19% | 52W Low | 60.54 39.99% | Perf 3Y | 65.82% |
| Dividend Est. | 0.72 (0.85%) | EV/EBITDA | 18.25 | Sales past 3/5Y | -0.10% 4.12% | Gross Margin | 48.45% | Volatility | 3.02% 2.54% | Perf 5Y | 92.75% |
| Dividend TTM | 0.72 (0.85%) | EV/Sales | 3.32 | EPS Y/Y TTM | 16.15% | Oper. Margin | 17.08% | ATR (14) | 2.42 | Perf 10Y | - |
| Dividend Ex-Date | Sep 01, 2026 | Quick Ratio | 1.10 | Sales Y/Y TTM | 5.35% | Profit Margin | 5.66% | RSI (14) | 53.78 | Recom | 2.43 |
| Dividend Gr. 3/5Y | 6.47% 6.13% | Current Ratio | 1.52 | EPS Q/Q | 4.55% | SMA20 | 2.96% | Beta | 0.56 | Target Price | 95.38 |
| Payout | 47.97% | Debt/Eq | 0.11 | Sales Q/Q | -1.19% | SMA50 | 1.56% | Rel Volume | 0.92 | Prev Close | 85.90 |
| Employees | 21,500 | LT Debt/Eq | 0.07 | Earnings | Nov 03 | SMA200 | 9.24% | Avg Volume | 4.57M | Price | 84.75 |
| IPO Date | May 24, 2019 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 2.88% -3.32% | Net Debt/EBITDA | 0.77 | Volume | 4,212,091 | Change | -1.34% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Aug-03-26 | Reiterated | Deutsche Bank | Buy | $100 → $101 |
| Aug-03-26 | Reiterated | BMO Capital | Outperform | $86 → $100 |
| Jul-21-26 | Reiterated | RBC Capital | Outperform | $95 → $103 |
| Jul-14-26 | Reiterated | Mizuho | Outperform | $96 → $97 |
| Jul-02-26 | Reiterated | Mizuho | Outperform | $82 → $96 |
| Jun-11-26 | Reiterated | Barclays | Overweight | $75 → $91 |
| Jun-09-26 | Reiterated | UBS | Neutral | $88 → $86 |
| May-28-26 | Reiterated | Morgan Stanley | Overweight | $84 → $95 |
| Apr-24-26 | Reiterated | RBC Capital | Outperform | $89 → $95 |
| Apr-21-26 | Reiterated | Wells Fargo | Overweight | $85 → $90 |
Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was founded in 1802 and is headquartered in Indianapolis, Indiana.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 17,812 | 17,401 | 16,908 | — | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 9,182 | 9,172 | 9,529 | — | — | — | — | — | — | |
| Gross Profit | 8,630 | 8,229 | 7,379 | — | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 3,614 | 3,492 | 3,196 | — | — | — | — | — | — | |
| Research and Development | 1,493 | 1,474 | 1,402 | — | — | — | — | — | — | |
| Other Operating Expense | 481 | 644 | 685 | — | — | — | — | — | — | |
| Operating Income | 3,042 | 2,619 | 2,096 | — | — | — | — | — | — | |
| Interest Expense | 175 | 180 | 233 | — | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -1,284 | -751 | -588 | — | — | — | — | — | — | |
| Net Income Before Taxes | 1,583 | 1,688 | 1,275 | — | — | — | — | — | — | |
| Income Taxes | 486 | 484 | 412 | — | — | — | — | — | — | |
| Consolidated Net Income | 1,009 | 1,094 | 907 | — | — | — | — | — | — | |
| Net Income From Continuing Operations | 1,097 | 1,204 | 863 | — | — | — | — | — | — | |
| Net Income | 1,009 | 1,094 | 907 | — | — | — | — | — | — | |
| EPS (Recurring) | 1.51 | 1.60 | 1.31 | — | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 1.51 | 1.60 | 1.31 | — | — | — | — | — | — | |
| EPS (Diluted) | 1.51 | 1.60 | 1.30 | — | — | — | — | — | — | |
| EBITDA | 3,243 | 3,071 | 2,735 | — | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 56.13 | 41.89 | 43.82 | — | — | — | — | — | — | |
| Price To Sales Ratio | 3.19 | 2.62 | 2.34 | — | — | — | — | — | — | |
| Gross Margin | 48.45 | 47.29 | 43.64 | — | — | — | — | — | — | |
| Operating Margin | 17.08 | 15.05 | 12.40 | — | — | — | — | — | — | |
| Net Margin | 5.66 | 6.29 | 5.36 | — | — | — | — | — | — | |
| Shares Outstanding | 670 | 680 | 694 | — | — | — | — | — | — | |
| Market Capitalization | 56,783 | 45,580 | 39,530 | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| TITUS BRIAN | See Remarks | Feb 20 '26 | Option Exercise | 50.70 | 4,311 | 218,568 | 16,401 | Feb 24 |
| TITUS BRIAN | See Remarks | Feb 20 '26 | Sale | 76.55 | 8,311 | 636,200 | 8,090 | Feb 24 |
| King Robert D. | EVP, Crop Protection Business | Aug 29 '25 | Option Exercise | 60.06 | 24,297 | 1,459,305 | 86,517 | Sep 02 |
| King Robert D. | EVP, Crop Protection Business | Aug 29 '25 | Sale | 74.20 | 37,280 | 2,765,993 | 49,262 | Sep 02 |
| FUERER CORNEL B | See Remarks | May 13 '25 | Option Exercise | 50.70 | 17,242 | 874,169 | 156,883 | May 15 |
| FUERER CORNEL B | See Remarks | May 13 '25 | Sale | 68.06 | 55,242 | 3,759,771 | 101,641 | May 15 |
| TITUS BRIAN | See Remarks | Feb 20 '25 | Option Exercise | 37.30 | 21,560 | 804,296 | 37,907 | Feb 24 |
| TITUS BRIAN | See Remarks | Feb 20 '25 | Sale | 63.74 | 26,560 | 1,692,934 | 11,347 | Feb 24 |
| Magro Charles V. | Chief Executive Officer | Feb 19 '25 | Sale | 63.82 | 46,905 | 2,993,477 | 231,896 | Feb 20 |
| FUERER CORNEL B | SVP, Gen Counsel and Secretary | Nov 26 '24 | Sale | 63.40 | 37,672 | 2,388,367 | 126,961 | Nov 27 |
| FUERER CORNEL B | SVP, Gen Counsel and Secretary | Nov 26 '24 | Option Exercise | 45.15 | 37,672 | 1,700,891 | 164,633 | Nov 27 |
| FUERER CORNEL B | SVP, Gen Counsel and Secretary | May 14 '24 | Option Exercise | 31.22 | 39,736 | 1,240,558 | 166,334 | May 16 |
| FUERER CORNEL B | SVP, Gen Counsel and Secretary | May 14 '24 | Sale | 57.41 | 39,736 | 2,281,244 | 126,628 | May 16 |
| Eathington Samuel R | See Remarks | May 09 '24 | Option Exercise | 33.48 | 31,686 | 1,060,847 | 85,511 | May 13 |
| Eathington Samuel R | See Remarks | May 09 '24 | Sale | 57.64 | 31,686 | 1,826,381 | 53,854 | May 13 |